Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2007-03-27
2007-03-27
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
10480145
ABSTRACT:
A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammatory response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.
REFERENCES:
patent: 3552975 (1971-01-01), Worden
patent: 3720517 (1973-03-01), Bavisotto et al.
patent: 3932603 (1976-01-01), Haas
patent: 3933919 (1976-01-01), Wilkinson
patent: 3965188 (1976-06-01), Westermann et al.
patent: 4123561 (1978-10-01), Grant
patent: 4133903 (1979-01-01), Thiele et al.
patent: 4154865 (1979-05-01), Grant
patent: 4401684 (1983-08-01), Versluys
patent: 4554170 (1985-11-01), Panzer et al.
patent: 4644084 (1987-02-01), Cowles et al.
patent: 4692280 (1987-09-01), Spinelli
patent: 4767640 (1988-08-01), Goldstein et al.
patent: 5006337 (1991-04-01), Motitschke et al.
patent: 5013571 (1991-05-01), Hay
patent: 5073396 (1991-12-01), Todd, Jr.
patent: 5082975 (1992-01-01), Todd, Jr. et al.
patent: 5155276 (1992-10-01), Paul
patent: 5166449 (1992-11-01), Todd, Jr. et al.
patent: 5264236 (1993-11-01), Ogasahara et al.
patent: 5286506 (1994-02-01), Millis et al.
patent: 5296637 (1994-03-01), Stegink et al.
patent: 5387425 (1995-02-01), Hsu et al.
patent: 5604263 (1997-02-01), Tobe et al.
patent: 5827895 (1998-10-01), Nutter et al.
patent: 6020019 (2000-02-01), Ting et al.
patent: 6129907 (2000-10-01), Sreenivasan et al.
patent: 6383527 (2002-05-01), Artman et al.
patent: 6391346 (2002-05-01), Newmark et al.
patent: 6583322 (2003-06-01), Shalai et al.
patent: 2002/0076452 (2002-06-01), Babish et al.
patent: 2002/0077299 (2002-06-01), Babish et al.
patent: 2002/0086062 (2002-07-01), Kuhrts
patent: 2002/0086070 (2002-07-01), Kuhrts
patent: 2003/0096027 (2003-05-01), Babish et al.
patent: 2003/0113393 (2003-06-01), Babish et al.
patent: 2003/0133958 (2003-07-01), Kuno et al.
patent: 2004/0137096 (2004-07-01), Kuhrts
patent: 2004/0219240 (2004-11-01), Babish et al.
patent: 19841615 (2000-03-01), None
patent: 04202138 (1992-07-01), None
patent: 406312924 (1994-11-01), None
patent: 07194351 (2000-09-01), None
patent: 2045955 (1995-10-01), None
Chemistry and Analysis of Hop and Beer Bitter Acids, Elsevier, 1991, Eds., Verzele, M, and De Keukeleire, Chapters 5 and 6.
Friedman, et al., J Cutan Med. Surg. 6(5):449-459 (2002).
Plewig, et al., J Invest. Dermatol. 65(6):532-536 (1975).
Jach, Przegl Dermatol. 65(4):379-382 (1978).
Bermejo, et al. Rev. Esp. Enferm. Dig. 95: 621-624 and 625-628 (2003).
Brown, et al. J Chem. Soc. 545 (1959).
Byrne, et al. J. Chem. Soc. (C):2810 (1971).
Carroccio, et al. Clin. Chem. 49:861-867 (2003).
Carson, J. Am. Chem. Soc. 73:1850-1851 (1951).
Charlier, et al. Eur. J. Med. Chem. 38:645-659 (2003).
Chou, et al. Adv Enzyme Regul 22:27-55 (1984).
Chou, et al. Eur. J. Biochem. 115:207-216 (1981).
Chou, et al. J. Biol. Chem. 252:6438-6442 (1977).
Chou, et al. J. Theor. Biol. 35:285-297 (1972).
Chou, J. Theor. Biol. 59:253-276 (1976).
Chou, et al. Trends Pharmacol. Sci. 4:450-454 (1983).
Costa, et al. Digest. Liver Dis. 35:642-647 (2003).
Goldstein, et al. Am. J. Gastroenterol. 96:1019-1027 (2001).
Halter, et al. Gut 49:443-453 (2001).
Hammberg, et al. J. Bio. Chem. 246:6713-6721 (1971).
Kanematsu, et al. J Bone Miner Res 12(11):1789-1796 (1997).
Lopes, Curr. Med Res Opin. 8:145-149 (1982).
Meling, et al. Scand. J. Gastroenterol. 31:339-344 (1996).
Noreen, et al. J. Nat. Prod 61:2-7 (1998).
Thomas M. Newmark and Paul Schulick, Beyond Aspirin Nature's Answer to Arthritis, Cancer & Alzheimer's Disease, Hohm Press (2000).
Pairet, et al. Inflamm. Res 47, Supplement 2S93-S101 (1998).
Panglisch, Monafsschrift fuer Brauwissen Schaft, 1990, 43(1), 4-16.
Ringbom, et al. J. Nat Prod 61:1212-1215 (1998).
Pippa, et al. Scand. J. Gastroenterol. Suppl. 167:32-35 (1989).
Poullis, et al. J. Gastroenterol. Hepatol. 18:756-762 (2003).
Røseth, Digest. Liver Dis. 35:607-609 (2003).
Shah, et al. Gut 48:339-346 (2001).
Schjerven, et al. Br. J. Dermatol. 149:484-491 (2003).
Sivri, Fundam. Clinic. Pharmacol. 18:23-31 (2004).
Tagashira, et al. Biosci. Biotech. Biochem. 59(4):740-742 (1996).
Tibble, et al. Gut 45:362-366 (1999).
Tobe, et al. Biosci. Biotech. Biochem 61(1):158-159 (1997).
Yui, et al. Biol. Pharm. Bull. 26:753-760 (2003).
Warner, et al. Proc Natl Acad Sci USA 96:7563-7568 (1999).
Yamamoto, FEBS Letters 465:103-106 (2000).
“Information on Zyflamend and Zyflamend PM”, downloaded from and Internet Aug. 30, 2002.
“Information on ArthroTrimTM product”, downloaded from Internet Aug. 30, 2002.
Information on a book titled “Beyond Aspirin”, by Thomas Newmark, et al., Release Jul. 2000; pp. 147-151, 248.
Germany, “The Absolutely German Drink,” contents of beer, 2004, 5 pages.
Babish John G.
Howell Terrence M.
McDermott Will & Emer, LLP
Meller Michael
Metaproteomics, LLC
LandOfFree
Complex mixtures exhibiting selective inhibition of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Complex mixtures exhibiting selective inhibition of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complex mixtures exhibiting selective inhibition of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791024